UnitedHealth Group Incorporated $UNH Holdings Raised by Adage Capital Partners GP L.L.C.

Key Points

• Adage Capital Partners GP L.L.C. increased its stake in UnitedHealth Group by 0.3%, holding 914,051 shares valued at approximately $478.7 million, making it the firm's 16th largest portfolio holding.
• Wall Street analysts have mixed forecasts for UnitedHealth Group, with target prices ranging from $270 to $440 and a consensus rating of "Moderate Buy" based on 15 Buy, 6 Hold, and 3 Sell ratings.
• UnitedHealth Group plans to pay a quarterly dividend of $2.21 per share on September 23rd, with a annualized payout of $8.84 and a dividend yield of 2.9%.

Adage Capital Partners GP L.L.C. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.3% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 914,051 shares of the healthcare conglomerate's stock after acquiring an additional 2,429 shares during the period. UnitedHealth Group accounts for 0.9% of Adage Capital Partners GP L.L.C.'s investment portfolio, making the stock its 16th biggest holding. Adage Capital Partners GP L.L.C. owned 0.10% of UnitedHealth Group worth $478,734,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC lifted its stake in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Algert Global LLC increased its position in UnitedHealth Group by 5.3% during the fourth quarter. Algert Global LLC now owns 3,175 shares of the healthcare conglomerate's stock worth $1,606,000 after buying an additional 160 shares during the last quarter. BIP Wealth LLC lifted its position in shares of UnitedHealth Group by 38.4% in the fourth quarter. BIP Wealth LLC now owns 844 shares of the healthcare conglomerate's stock worth $427,000 after buying an additional 234 shares during the last quarter. Finally, Cary Street Partners Financial LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $11,477,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, HSBC restated a "reduce" rating and issued a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $353.00.

UnitedHealth Group Price Performance

NYSE:UNH opened at $309.77 on Tuesday. The company has a market capitalization of $280.55 billion, a price-to-earnings ratio of 13.42, a PEG ratio of 2.00 and a beta of 0.44. The company has a 50-day moving average of $288.34 and a 200-day moving average of $378.14. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the business earned $6.80 EPS. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.